These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24217697)

  • 1. Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.
    Hurtado FK; Weber B; Derendorf H; Hochhaus G; Dalla Costa T
    Antimicrob Agents Chemother; 2014; 58(2):678-86. PubMed ID: 24217697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.
    Zimmermann ES; Laureano JV; Dos Santos CN; Schmidt S; Lagishetty CV; de Castro WV; Dalla Costa T
    Antimicrob Agents Chemother; 2016 Feb; 60(2):946-54. PubMed ID: 26621623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis.
    K Hurtado F; Laureano JV; de A Lock G; Derendorf H; Dalla Costa T
    Int J Antimicrob Agents; 2014 Oct; 44(4):327-33. PubMed ID: 25218157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures.
    Szerkus O; Jacyna J; Wiczling P; Gibas A; Sieczkowski M; Siluk D; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():48-59. PubMed ID: 27423043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of unbound levofloxacin by simultaneous microdialysis in rat pancreas after intravenous and oral doses.
    Liu D; Xu S; Xiao H; Wang Z; Mao N; Zhou J; Liu R; Huang Y
    J Pharm Pharmacol; 2014 Sep; 66(9):1215-21. PubMed ID: 24961375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic modeling to establish the role of P-glycoprotein on ciprofloxacin distribution to lung and prostate following intravenous and intratracheal administration to Wistar rats.
    Zimmermann ES; de Miranda Silva C; Neris C; Torres BGDS; Schmidt S; Dalla Costa T
    Eur J Pharm Sci; 2019 Jan; 127():319-329. PubMed ID: 30423435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Reponse Exemplified by Levofloxacin.
    Busse D; Schaeftlein A; Solms A; Ilia L; Michelet R; Zeitlinger M; Huisinga W; Kloft C
    Pharm Res; 2021 Mar; 38(3):381-395. PubMed ID: 33723793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure.
    Ullah S; Matzneller P; Zeitlinger M; Fuhr U; Taubert M
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1097-1106. PubMed ID: 31062064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First plasma and tissue pharmacokinetic study of the YSNSG cyclopeptide, a new integrin antagonist, using microdialysis.
    Slimano F; Djerada Z; Bouchene S; Van Gulick L; Brassart-Pasco S; Dukic S
    Eur J Pharm Sci; 2017 Jul; 105():178-187. PubMed ID: 28512055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
    Aboubakr M; Uney K; Elmas M
    Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.
    Preston SL; Drusano GL; Berman AL; Fowler CL; Chow AT; Dornseif B; Reichl V; Natarajan J; Wong FA; Corrado M
    Antimicrob Agents Chemother; 1998 May; 42(5):1098-104. PubMed ID: 9593134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
    Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamsulosin alters levofloxacin pharmacokinetics in prostates derived from rats with acute bacterial prostatitis.
    Qin GD; Xiao MZ; Zhou YD; Yang J; He HX; He Y; Zeng Y
    Asian J Androl; 2013 Mar; 15(2):254-60. PubMed ID: 23353720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung microdialysis study of levofloxacin in rats following intravenous infusion at steady state.
    Marchand S; Frasca D; Dahyot-Fizelier C; Breheret C; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3074-7. PubMed ID: 18591278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental stage and infection status may affect drug distribution in the prostate of rats.
    Xu Z; Sun L; Yin C; Wu H; Wang X; Yang Y; Wang Z
    Xenobiotica; 2024 May; 54(5):248-256. PubMed ID: 38634734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.
    Torres BGS; Helfer VE; Bernardes PM; Macedo AJ; Nielsen EI; Friberg LE; Dalla Costa T
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary pharmacokinetics of levofloxacin in rats after aerosolization of immediate-release chitosan or sustained-release PLGA microspheres.
    Gaspar MC; Grégoire N; Sousa JJ; Pais AA; Lamarche I; Gobin P; Olivier JC; Marchand S; Couet W
    Eur J Pharm Sci; 2016 Oct; 93():184-91. PubMed ID: 27531420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
    Drusano GL; Preston SL; Van Guilder M; North D; Gombert M; Oefelein M; Boccumini L; Weisinger B; Corrado M; Kahn J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2046-51. PubMed ID: 10898674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.
    Kervezee L; Stevens J; Birkhoff W; Kamerling IM; de Boer T; Dröge M; Meijer JH; Burggraaf J
    Br J Clin Pharmacol; 2016 Feb; 81(2):256-68. PubMed ID: 26852745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections.
    Kontou P; Manika K; Chatzika K; Papaioannou M; Sionidou M; Pitsiou G; Kioumis I
    Int J Antimicrob Agents; 2013 Sep; 42(3):262-7. PubMed ID: 23830621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.